Advertisement
Journal Articles
Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C
C.Y. Chung, H.P. Erickson
Journal of Cell Science 1997 110: 1413-1419;

Summary

We have investigated the role of glycosaminoglycans in fibronectin matrix assembly and the incorporation of tenascin-C into matrix fibrils. Chinese hamster ovary cell mutants with a total block in heparan and chondroitin sulfate production failed to assemble a fibronectin matrix, and incorporated no tenascin-C. Another mutant with reduced heparan sulfate produced a normal fibronectin matrix but failed to incorporate tenascin-C. Excess soluble glycosaminoglycans inhibited the binding of tenascin-C to purified fibronectin in ELISA, and completely blocked incorporation into matrix fibrils. Treating cultured cells with xyloside, which interferes with glycosaminoglycan attachment to proteoglycans, also completely blocked their ability to incorporate tenascin-C into matrix fibrils. We conclude that proteoglycans bound to fibronectin fibrils play a major role in binding tenascin-C to these fibrils. We examined more closely the large heparan sulfate proteoglycan, perlecan, and found that it co-localizes with tenascin-C and fibronectin in the matrix. The perlecan binding site in tenascin-C was mapped to the fibronectin type III domains 3–5, but this binding was strongly enhanced for the small splice variant, which is the major form incorporated into the matrix. Apparently when the alternative splice segment is inserted after domain 5 it inhibits perlecan binding. Thus heparan sulfate glycosaminoglycans, and perlecan in particular, may play a role in incorporation of the small splice variant of tenascin-C into fibronectin matrix fibrils.

REFERENCES

    1. Aukhil I.,
    2. Slemp C. A.,
    3. Lightner V. A.,
    4. Nishimura K.,
    5. Briscoe G. and
    6. Erickson H. P.
    (1990). Purification of hexabrachion (tenascin) from cell culture conditioned medium, and separation from a cell adhesion factor. Matrix 10, 98–111
    OpenUrlCrossRefPubMedWeb of Science
    1. Aukhil I.,
    2. Joshi P.,
    3. Yan Y. and
    4. Erickson H. P.
    (1993). Cell-and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. J. Biol. Chem 268, 2542–2553
    OpenUrlAbstract/FREE Full Text
    1. Bame K. J. and
    2. Esko J. D.
    (1989). Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase. J. Biol. Chem 264, 8059–8065
    OpenUrlAbstract/FREE Full Text
    1. Barnea G.,
    2. Grumet M.,
    3. Milev P.,
    4. Silvennoinen O.,
    5. Levy J. B.,
    6. Sap J. and
    7. Schlessinger J.
    (1994). Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. J. Biol. Chem 269, 14349–14352
    OpenUrlAbstract/FREE Full Text
    1. Battaglia C.,
    2. Mayer U.,
    3. Aumailley M. and
    4. Timpl R.
    (1992). Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. Eur. J. Biochem 208, 359–366
    OpenUrlPubMedWeb of Science
    1. Canfield A. E. and
    2. Schor A. M.
    (1995). Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J. Cell Sci 108, 797–809
    OpenUrlAbstract/FREE Full Text
    1. Chiquet M. and
    2. Fambrough D. M.
    (1984). Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J. Cell Biol 98, 1937–1946
    OpenUrlAbstract/FREE Full Text
    1. Chiquet M. and
    2. Fambrough D. M.
    (1984). Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J. Cell Biol 98, 1926–1936
    OpenUrlAbstract/FREE Full Text
    1. Chiquet-Ehrismann R.,
    2. Kalla P.,
    3. Pearson C. A.,
    4. Beck K. and
    5. Chiquet M.
    (1988). Tenascin interferes with fibronectin action. Cell 53, 383–390
    OpenUrlCrossRefPubMedWeb of Science
    1. Chiquet-Ehrismann R.,
    2. Matsuoka Y.,
    3. Hofer U.,
    4. Spring J.,
    5. Bernasconi C. and
    6. Chiquet M.
    (1991). Tenascin variants: Differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul 2, 927–938
    OpenUrlPubMedWeb of Science
    1. Chung C. Y.,
    2. Zardi L. and
    3. Erickson H. P.
    (1995). Binding of tenascin-C to soluble fibronectin and matrix fibrils. J. Biol. Chem 270, 29012–29017
    OpenUrlAbstract/FREE Full Text
    1. Dische Z.
    (1947). A new specific color reaction of hexuronic acids. J. Biol. Chem 167, 189–198
    OpenUrlFREE Full Text
    1. Engvall E. and
    2. Ruoslahti E.
    (1977). Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer 20, 1–5
    OpenUrlCrossRefPubMedWeb of Science
    1. Erickson H. P. and
    2. Bourdon M. A.
    (1989). Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol 5, 71–92
    OpenUrlCrossRefWeb of Science
    1. Erickson H. P.
    (1993). Tenascin-C, tenascin-R and tenascin-X: A family of talented proteins in search of functions. Curr. Opin. Cell Biol 5, 869–876
    OpenUrlCrossRefPubMed
    1. Esko J. D.
    (1991). Genetic analysis of proteoglycan structure, function, and metabolism. Curr. Opin. Cell Biol 3, 805–816
    OpenUrlCrossRefPubMed
    1. Fischer D.,
    2. Chiquet-Ehrismann R.,
    3. Bernasconi C. and
    4. Chiquet M.
    (1995). A single heparin binding region within the fibrinogen-like domain is functional in chick tenascin-C. J. Biol. Chem 270, 3378–3384
    OpenUrlAbstract/FREE Full Text
    1. Gauer S.,
    2. Schulzelohoff E.,
    3. Schleicher E. and
    4. Sterzel R. B.
    (1996). Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin. Eur. J. Cell Biol 70, 233–242
    OpenUrlPubMedWeb of Science
    1. Grumet M.,
    2. Milev P.,
    3. Sakurai T.,
    4. Karthikeyan L.,
    5. Bourdon M.,
    6. Margolis R. K. and
    7. Margolis R. U.
    (1994). Interaction with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. J. Biol. Chem 269, 12142–12146
    OpenUrlAbstract/FREE Full Text
    1. Heremans A.,
    2. Cassiman J.-J.,
    3. van den Berghe H. and
    4. David G.
    (1988). Heparan sulfate proteoglycan from the extracellular matrix of human lung fibroblasts: Isolation, purification, and core protein characterization. J. Biol. Chem 263, 4731–4739
    OpenUrlAbstract/FREE Full Text
    1. Heremans A.,
    2. De Cock B.,
    3. Cassiman J.-J.,
    4. van den Berghe H. and
    5. David G.
    (1990). The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin. J. Biol. Chem 265, 8716–8724
    OpenUrlAbstract/FREE Full Text
    1. Hiraiwa N.,
    2. Kida H.,
    3. Sakakura T. and
    4. Kusakabe M.
    (1993). Induction of tenascin in cancer cells by interactions with embryonic mesenchyme mediated by a diffusible factor. J. Cell Sci 104, 289–296
    OpenUrlAbstract/FREE Full Text
    1. Hoffman S. and
    2. Edelman G. M.
    (1987). A proteoglycan with HNK-1 antigenic determinants is a neuron-associated ligand for cytotactin. Proc. Nat. Acad. Sci. USA 84, 2523–2527
    OpenUrlAbstract/FREE Full Text
    1. Joshi P.,
    2. Chung C.-Y.,
    3. Aukhil I. and
    4. Erickson H. P.
    (1993). Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J. Cell Sci 106, 389–400
    OpenUrlAbstract/FREE Full Text
    1. Leahy D. J.,
    2. Aukhil I. and
    3. Erickson H. P.
    (1996). 2.0 Å crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 84, 155–164
    OpenUrlCrossRefPubMedWeb of Science
    1. Lidholt K.,
    2. Weinke J. L.,
    3. Kiser C. S.,
    4. Lugemwa F. N.,
    5. Bame K. J.,
    6. Cheifetz S.,
    7. Massague J.,
    8. Lindahl U. and
    9. Esko J. D.
    (1992). A single mutation affects both N -acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc. Nat. Acad. Sci. USA 89, 2267–2271
    OpenUrlAbstract/FREE Full Text
    1. Lightner V. A. and
    2. Erickson H. P.
    (1990). Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. J. Cell Sci 95, 263–277
    OpenUrlAbstract/FREE Full Text
    1. Milev P.,
    2. Friedlander D. R.,
    3. Sakurai T.,
    4. Karthikeyan L.,
    5. Flad M.,
    6. Margolis R. K.,
    7. Grumet M. and
    8. Margolis R. U.
    (1994). Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J. Cell Biol 127, 1703–1715
    OpenUrlAbstract/FREE Full Text
    1. Riou J.-F.,
    2. Shi D.-L.,
    3. Chiquet M. and
    4. Boucaut J.-C.
    (1988). Expression of tenascin in response to neural induction in amphibian embryos. Development 104, 511–524
    OpenUrlAbstract/FREE Full Text
    1. Salmivirta M.,
    2. Elenius K.,
    3. Vainio S.,
    4. Hofer U.,
    5. Chiquet-Ehrismann R.,
    6. Thesleff I. and
    7. Jalkanen M.
    (1991). Syndecan from embryonic tooth mesenchyme binds tenascin. J. Biol. Chem 266, 7733–7739
    OpenUrlAbstract/FREE Full Text
    1. Vaughan L.,
    2. Huber S.,
    3. Chiquet M. and
    4. Winterhalter K. H.
    (1987). A major, six-armed glycoprotein from embryonic cartilage. EMBO J 6, 349–353
    OpenUrlPubMedWeb of Science
    1. Weber P.,
    2. Zimmermann D. R.,
    3. Winterhalter K. H. and
    4. Vaughan L.
    (1995). Tenascin-C binds heparin by its fibronectin type III domain five. J. Biol. Chem 270, 4619–4623
    OpenUrlAbstract/FREE Full Text
    1. Weber P.,
    2. Ferber P.,
    3. Fischer R.,
    4. Winterhalter K. H. and
    5. Vaughan L.
    (1996). Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin. FEBS Lett 389, 304–308
    OpenUrlCrossRefPubMed
    1. Yamagata M.,
    2. Saga S.,
    3. Kato M.,
    4. Bernfield M. and
    5. Kimita K.
    (1993). Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cell-substratum adhesion. J. Cell Sci 106, 55–65
    OpenUrlAbstract/FREE Full Text
    1. Zhang L. and
    2. Esko J. D.
    (1995). Accumulation of a pentasaccharide terminating in alpha-N-acetylyglucosamine in an animal cell mutant defective in heparan sulfate biosynthesis. J. Biol. Chem 270, 12557–12562
    OpenUrlAbstract/FREE Full Text
Back to top

 Download PDF

Email
Journal Articles
Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C
C.Y. Chung, H.P. Erickson
Journal of Cell Science 1997 110: 1413-1419;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Alerts

Article navigation

Other journals from The Company of Biologists

Advertisement

2020 at The Company of Biologists

Despite the challenges of 2020, we were able to bring a number of long-term projects and new ventures to fruition. While we look forward to a new year, join us as we reflect on the triumphs of the last 12 months.

Mole – The Corona Files

"This is not going to go away, 'like a miracle.' We have to do magic. And I know we can."

Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.

Cell scientist to watch – Christine Faulkner

In an interview, Christine Faulkner talks about where her interest in plant science began, how she found the transition between Australia and the UK, and shares her thoughts on virtual conferences.

Read & Publish participation extends worldwide

“The clear advantages are rapid and efficient exposure and easy access to my article around the world. I believe it is great to have this publishing option in fast-growing fields in biomedical research.”

Dr Jaceques Behmoaras (Imperial College London) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 60 institutions in 12 countries taking part – find out more and view our full list of participating institutions.

JCS and COVID-19

For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.

If you have any questions or concerns, please do not hestiate to contact the Editorial Office.